Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IR has stated on several occasions that Anavex has a plan for uplisting and when the time is right they will make it public. This leads me to believe that they are already in discussions with other pharma's looking to enhance there pipelines. Buyout or partnership? One thing to remember Missling was an investment banker and as I have stated before these guys think big, see big, and do big. Buyout is my bet. Time will tell but I'm looking forward to the developments down the road.
My personal belief is we will be bought out. Big pharma is looking to enhance there pipelines and getting in earlier with Anavex will cost them less then if they were to wait until let's say positive phase III. My very first conversation with Missling he spoke about one reason he joined Anavex was he was searching for the next 10 bagger. Well I imagine he won't be waiting to much longer. I'm turning all my friends and close business colleagues onto this "diamond in the rough." Alzheimer's is a market that any big pharma would love to control and Anavex might just be the solution or the fix. We will be bought out way before any phase III begins. Just my 2 cents.
Rwings can that even be possible? Part B is26 week follow-up for long-term effectiveness. Not enough time between first patient enrolled and now. I don't know Missling made sure I was aware this release ahead of schedule is positive.
I already told you. His message was that my interpretation of the PR was incorrect. That this is extremely good news. N that they have decided to share info now because they have meaningful data now. That's it! It was brief but to the point.
Good stuff! I was completely wrong in my interpretation of the PR this morning. This early release is to be taken as positive and only that. Good night fellas and good luck!
Sheff new to board. Visit quite frequently however never post but thought I would clarify that the data release in July will take the place of September's release. This earlier release of data is to be taken as only a positive and not a negative as I first originally thought. They have significant data available to release to public now and do not have to wait for September. This play should get extremely interesting! Have great night !
Would you like to speak with him as well. Private message me and I will give you his number.
You have a problem with what I did?
yes should i copy all my emails and post for you! yea let me do that.
Thank you for the response to my email. However earlier in Q2 I was told that by the end of Q2 there would be an enrollment update so the question is was this announcement of interim data planned or has something of significance came about in the trial? Also with this update now for July 23rd will there also be an announcement in September as originally planned? Thanks again for your help!
Timothy Whelan Jr.
President
W&T CAPITAL
411 Meridian Av. Suite #3
Miami Beach, FL 33139
786-532-3673
---- On Tue, 30 Jun 2015 12:43:58 -0400 Christine Payne <cpayne@primorisgroup.com> wrote ----
Dear Timothy,
Thank you for your email and continued interest in Anavex Life Sciences Corp.
The announcement of interim clinical data in early Q3 makes it redundant to detail enrollment status.
A press release will be issued in parallel to the poster presentation at AAIC.
Please do not hesitate to contact our office if we can be of further assistance.
Hello Dr. Missling we have spoken before in regards to a few issues however I'm reaching out to you now cause this PR release this morning has me extremely worried and confused. Investor relations told me that this upcoming data release in July will take the place for the original release that was scheduled for September. I can only assume that the trial isn't going according to plan so with that being said what is your next step with Anavex 2-73? Or will you be moving onto Anavex 3-71? Also will the phase 2a be discontinued or will the patients continue to be followed for efficacy? I realize that the trial is in two parts A and B but by presenting the data now was it a decision based on preserving cash for the future?
Thank you Dr. Missling for reaching out and calling me. I must say I'm excited even more now than before the call. Thanks for all your help and hardwork!
This PR was nothing but great news and thats the only way it should be interpreted. I was wrong but I have recently lost my a** on these bios so I look at everything under a microscope.
OK sorry boys I got scared. I wrote an email to Dr. Missling and 5 mins later he calls and totally puts my nerves to rest. Hang on boys its about to get crazy here.
How is that? Read the FDA website for adaptive trial designs if you are questioning me. Look I hope they are onto something but this to me just smells fishy.
ok... and that means what?
Adaptive trial design allows you to do just that adapt the trial mid-way through it course. I'm starting to believe they saw no efficacy and shut it down.
Because of the results being released in July and not September it was redundant.
If results were not good why would they want to immediately get this out?
Can't be full data cause part B is 36 week follow. PR says initial data and I would assume just results from Part A of study.
So just getting off phone with IR and this July data is Septembers data. It has come early. I don't know what to think about this? Any ideas anyone?
Yes this is open label and I'm also almost certain for positive results but not because they are presenting at a conference. I have been apart of many bios where they presented bad data at scientific conferences just like the AAIC. But Anavex will announce positive results.
Rwings if you could elaborate. I don't understand how this stuff works. How is this a positive? I know the PR is positive but how does this now convince you that we have something so much bigger? If you have time bro. I know that you probably have stuff on your desk of more importance right now. When you can.
Ok... This data is on the first patient. I can almost guarantee that this initial data release is not a substitute for Septembers release. September's release will be on significantly more patients.
Poster presentation details - states first patient data? But guess is as good as mine.
Nothing to elaborate on. You posted "would they release data so early if it wasn't positive?" My statement was informing peeps on this board that this initial data is from the first patient. Nothing more nothing less. However I have written IR about the enrollment update. Hopefully will get there response today.
This data is from only the first patient.
I'm sure the data will be good however just because they are presenting it at the AAIC has no bearing on positive or negative results. Presenting the data at a Scientific gathering is done all the time even with negative results. This is a meeting of the minds. But yea I think it will be great stuff. But where is the enrollment update?
You think we fill the gap between. 45 -.46? It took sometime before with prior gap however this time around feels different?
No he didn't he just bumped up to .475. Once that is taken out watch he will come back with his fake ass 100,000 share ask.
Here we go again. This zig zag pattern is getting predictable.
yea buddy looking great now on level 2
Is it gonna stall out in this range again?
You must be off your meds?
Today definitely felt different. I admit once she broke yesterdays low of .36 I thought well another down day. Then around 2 pm I checked back and we were sitting at .40. Today's trading was different I don't know if its from pending news or if this is our breakout from our recent zig zag pattern? To be honest I really wasn't expecting our run-up to data to begin until late July or early August but if it's here I won't complain.
Missling has credentials out the a**. MBA to Ph.D.
Yes sir and remember fellas any hints about efficacy of trial is a tell tell sign. Its open label he knows how the trial is going. Words like we are extremely excited about the interim data and so forth will be what I'm listening for!
yahoo average volume is based over 3 months.
I think these guys make great CEO's. At least from a companies shareholder perspective.
Don't take this wrong bro but Christopher Missling was in the same game. Investment Banker!
.30 and .42 are the warrants for maxim I do believe.
Upon reading some dialog on these plans apparently its the norm for purchases of 1000. However we should see more of these purchases quite often in the future maybe every month for the next 12 months or so. I would still love to find out when the plan was adopted. I will try to find out.